medicine to treat sexual dysfunction in a patient, medicine to treat erectile dysfunction in a patient, medicine to decrease the side effects associated with therapeutic agents to treat sexual dysfunction in a patient, method for making a medicine to treat sexual dysfunction in a patient a patient responsive marginally to the pde5 inhibitor, and use of the peptide ac-nle-cycle (-asp-his-d-phe-arg-trp-lys) -0h in the preparation of a medication

摘要

MEDICINE TO TREAT SEXUAL DYfunction IN A PATIENT, MEDICINE TO TREAT ERECTIVE DYfunction IN A PATIENT, MEDICINE TO REDUCE THE SIDE EFFECTS ASSOCIATED WITH TREATMENT OF SEXUAL DYfunction TO A MEDICAL DIFFICULAR DIAGNOSIS A PATIENT RESPONSIVE MARGINALLY TO THE PDE-5 INHIBITOR, AND USING AC-NLE-CYCLE (-ASP-HIS-D-PHE-ARP-TRP-LYS) -OH IN THE PREPARATION OF A MEDICINAL PRODUCT. The present invention relates to a multiple agent therapy for the treatment of sexual dysfunction, including male erectile dysfunction, with sequential administration of a phosphodiesterase V inhibitor type (PDE-5), such as sildenafil, preferably when the PDE inhibitor is used. -5 is administered by oral administration, and a 3 and / or 4 melanocortin receptor agonist such as Ac-Nle-Cycle (-Asp-His-D-Phe-Arg-Trp-Lys) -OH (EN -141), preferably when PT-141 is formulated for and administered intranasally and additionally preferred when the PDE-5 inhibitor is administered prior to PT-141.